Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

CHAD THERAPEUTICS INC (CTU)

Income Statement Business | Geographic

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-08Mar-31-08Dec-31-07Sep-30-07Jun-30-07Mar-31-07Dec-31-06Sep-30-06
   10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q
Revenues:  
    United States    2.52.63.6 3.83.8
    Europe    0.20.30.1 0.11.0
    All other countries    0.10.10.2 0.10.1
    Japan    0.10.10.1 0.10.1
    Other    0.00.2-3.9 0.30.1
Total revenues  0.0 2.93.20.04.24.35.0
            Revenue growth   [+]  -32.0%-35.7%-100.0%-18.6%-27.1%-7.3%
Cost of goods sold  0.0 1.82.60.03.43.23.4
Gross profit  0.0 1.20.60.00.81.11.6
            Gross margin  100.0% 39.6%18.7% 19.3%24.6%32.5%
Selling, general and administrative  0.4 1.51.40.60.51.41.7
Research and development  0.2 0.40.40.2 0.40.3
EBITDA   [+]-0.6 -0.7-1.2-0.7 -0.7-0.3
            EBITDA margin  -1903.3% -22.4%-36.3% -26.3%-15.5%-5.6%
Depreciation  0.0 0.10.00.1 0.10.1
EBITA  -0.6 -0.7-1.2-0.8-1.1-0.7-0.4
            EBITA margin  -1913.3% -24.9%-37.4% -26.3%-17.3%-7.6%
Amortization of intangibles  0.0 0.00.00.10.00.00.0
EBIT   [+]-0.6 -0.7-1.2-0.9-1.1-0.8-0.4
            EBIT margin  -1936.7% -25.2%-37.4% -26.5%-17.6%-7.8%
Interest expense, net   [+]  0.10.20.0-0.1  
Other income (expense), net       -0.10.00.0
Pre-tax income  -0.6 -0.9-1.4-0.9-1.1-0.7-0.4
Income taxes  0.0 0.00.00.01.4-0.3-0.1
            Tax rate  0.0% 0.0%0.0%  41.2%17.3%
Net income  -0.6 -0.9-1.4-1.3-2.6-0.4-0.3
            Net margin  -1936.7% -29.6%-42.2% -60.6%-10.1%-6.2%
   
Basic EPS   [+]($0.06) ($0.09)($0.13)($0.09)($0.25)($0.04)($0.03)
Diluted EPS   [+]($0.06) ($0.09)($0.13)($0.09)($0.25)($0.04)($0.03)
   
Shares outstanding (basic)   [+]10.2 10.210.210.210.210.210.2
Shares outstanding (diluted)   [+]10.2 10.210.210.210.210.210.2
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy